Altimmune (ALT) Other Accumulated Expenses (2014 - 2026)
Altimmune (ALT) reported Other Accumulated Expenses of $313000.0 for Q1 2026, up 458.93% year-over-year from $56000.0 in Q1 2025, and down 0.63% on a QoQ basis from $315000.0 in Q4 2025.
Altimmune (ALT) has 9 years of Other Accumulated Expenses data on file, last reported at $313000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 458.93% year-over-year to $313000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $313000.0 (up 458.93% YoY) and the FY2025 annual result came in at $315000.0, up 472.73% from the prior year.
- Other Accumulated Expenses slipped to $313000.0 in Q1 2026 per ALT's latest filing, from $315000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $315000.0 in Q4 2025 and bottomed at $54000.0 in Q3 2024.
- The 5-year median for Other Accumulated Expenses is $103000.0 (2022), against an average of $137727.3.
- The widest annual swing landed in 2024, when Other Accumulated Expenses tumbled 55.65%; it then soared 472.73% in 2025.
- Tracing ALT's Other Accumulated Expenses over 5 years: stood at $103000.0 in 2022, then increased by 20.39% to $124000.0 in 2023, then plunged by 55.65% to $55000.0 in 2024, then soared by 472.73% to $315000.0 in 2025, then declined by 0.63% to $313000.0 in 2026.
- Per Business Quant, the three latest ALT Other Accumulated Expenses figures stand at $313000.0 (Q1 2026), $315000.0 (Q4 2025), and $177000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 313,000.00 |
| Dec 31, 2025 | 315,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Dec 31, 2022 | 103,000.00 |
| Mar 31, 2017 | 11,588.00 |
| Dec 31, 2016 | 11,588.00 |
| Sep 30, 2016 | 11,588.00 |
| Jun 30, 2016 | 11,588.00 |
| Dec 31, 2015 | 11,250.00 |
| Jun 30, 2015 | 74,233.00 |
| Mar 31, 2015 | 72,674.00 |
| Dec 31, 2014 | 70,326.00 |